Mark Nylen is a partner in the Corporate Practice. He regularly counsels both private and public companies on a variety of transactions, including mergers, acquisitions, venture capital financings and joint ventures. Mr. Nylen has significant experience advising both emerging and established companies in the life sciences, technology and financial services industries, among a range of other sectors.

Prior to joining WilmerHale, Mr. Nylen was a corporate associate at another large law firm in New York, where he advised on corporate governance matters and worked on both asset and equity acquisitions as well as mergers across a variety of industries.


    • TMX Group, in its strategic investment in VettaFi, a US-based, privately owned data, analytics, indexing, digital distribution, and thought leadership company
    • Gemini Therapeutics, a precision medicine company developing innovative treatments for genetically-defined age-related macular degeneration, in its merger with Disc Medicine, Inc., a privately held, clinical-stage biopharmaceutical company
    • DriveWealth, a pioneer in fractional investing and embedded finance, in its acquisition of Crypto-Systems, LLC, a company that offers tailored market-making services to platforms for digital assets to provide deep and stable liquidity
    • GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells therapies for immunology, in its $157 million Series A financing
    • Cloud9 Technologies LLC, a leader in integrated cloud-based communication solutions, in its acquisition by Symphony Communication Services Holdings
    • Zaius, a customer data platform bringing the context of the customer to the experience creation and optimization process of digital experiences, in its acquisition by Optimizely (formerly Episerver), a leading provider of digital experience platform solutions
    • PerkinElmer, a global leader committed to innovating for a healthier world, in its $591 million acquisition of Oxford Immunotec, a global leader of proprietary test kits for latent tuberculosis

Insights & News


  • Education

    • JD, University of Pennsylvania Law School, 2012

      Associate Editor, Journal of Business Law
    • BA, Communications, Boston College, 2008

      magna cum laude
  • Admissions

    • Massachusetts

    • New York